Benzinga's Top #PreMarket Gainers

shares gained 11.23 percent to $44.49 in the pre-market trading session. Roth Capital initiated coverage on Aduro Biotech with a Buy rating and a $74.00 price target.

shares surged 9.12 percent to $71.90 in pre-market trading after the company reported stronger-than-expected earnings for the first quarter.

shares climbed 7.95 percent to $28.50 in pre-market trading after jumping 15.28 percent on Friday

gained 7.87 percent to $2.33 in pre-market trading after the company reported the signing of a major solar module supply agreement with NextEra Energy Resources, LLC, a subsidiary of NextEra Energy Inc

.

shares rose 1.77 percent to $37.40 in pre-market trading after the bank reported stronger-than-expected results for the first quarter on Monday.